Key Segments:
By Test
-
Lipid Panel
-
Liver Panel
-
Renal Panel
-
Complete Blood Count
-
Electrolyte Testing
-
Infectious Disease Testing
-
Other Tests
By Product
-
Instruments
-
Reagents
-
Other Products
By End User
-
Hospital Laboratory
-
Diagnostic Laboratory
-
Point-of-care Testing
-
Other End Users
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Roche, Abbott, Siemens Healthineers, Danaher, Thermo Fisher Scientific, and bioMérieux.
Key opportunities include molecular diagnostics, automation, AI integration, and decentralized testing expansion.
Market growth is driven by chronic diseases, infectious diseases, preventive testing, and diagnostic innovation.
Infectious disease testing dominated the market due to high testing volumes and surveillance demand.
North America dominated in 2025, supported by advanced laboratories and high diagnostic testing adoption.
